ADMA Biologics Stock Options
| ADMA Stock | USD 16.73 0.86 4.89% |
ADMA Biologics' latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 0.65 with a put-to-call open interest ratio of 1.14 over 22 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on September 19th 2025. The total put volume is at 8.0, with calls trading at the volume of 36.0. This yields a 0.22 put-to-call volume ratio.
Open Interest Against September 19th 2025 Option Contracts
2025-09-19
The chart above shows ADMA Biologics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. ADMA Biologics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for ADMA Biologics' option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on ADMA Biologics
Analyzing ADMA Biologics' in-the-money options over time can help investors to take a profitable long position in ADMA Biologics regardless of its overall volatility. This is especially true when ADMA Biologics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money ADMA Biologics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with ADMA Biologics' stock while costing only a fraction of its price.
ADMA Biologics' stock options are financial instruments that give investors the right to buy or sell shares of ADMA Biologics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell ADMA stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If ADMA Biologics' stock price goes up or down, the stock options follow.
At present, ADMA Biologics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 513.1 M, whereas Common Stock Total Equity is forecasted to decline to about 19 K. ADMA Biologics In The Money Call Balance
When ADMA Biologics' strike price is surpassing the current stock price, the option contract against ADMA Biologics stock is said to be in the money. When it comes to buying ADMA Biologics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on ADMA Biologics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
ADMA Current Options Market Mood
ADMA Biologics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ADMA Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most ADMA Biologics' options investors are not very successful. ADMA Biologics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current ADMA contract
Base on the Rule 16, the options market is currently suggesting that ADMA Biologics will have an average daily up or down price movement of about 0.0406% per day over the life of the 2025-09-19 option contract. With ADMA Biologics trading at USD 16.73, that is roughly USD 0.006797. If you think that the market is fully incorporating ADMA Biologics' daily price movement you should consider buying ADMA Biologics options at the current volatility level of 0.65%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing ADMA Biologics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" ADMA calls. Remember, the seller must deliver ADMA Biologics stock to the call owner when a call is exercised.
ADMA Biologics Option Chain
When ADMA Biologics' strike price is surpassing the current stock price, the option contract against ADMA Biologics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
ADMA Biologics' option chain is a display of a range of information that helps investors for ways to trade options on ADMA. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ADMA. It also shows strike prices and maturity days for a ADMA Biologics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ADMA250919C00026000 | 0 | 26.0 | 0.0 - 0.85 | 0.85 | |
Call | ADMA250919C00025000 | 0 | 25.0 | 0.0 - 0.45 | 0.45 | |
Call | ADMA250919C00024000 | 0 | 24.0 | 0.0 - 0.2 | 0.2 | |
Call | ADMA250919C00023000 | 0 | 23.0 | 0.0 - 0.25 | 0.2 | |
Call | ADMA250919C00022000 | 0 | 22.0 | 0.0 - 0.4 | 0.4 | |
Call | ADMA250919C00021000 | 0 | 21.0 | 0.3 - 0.5 | 0.5 | |
Call | ADMA250919C00020000 | 0 | 20.0 | 0.0 - 0.7 | 0.85 | |
Call | ADMA250919C00019000 | 0 | 19.0 | 0.0 - 0.95 | 0.9 | |
Call | ADMA250919C00018000 | 0 | 18.0 | 0.0 - 1.25 | 1.15 | |
Call | ADMA250919C00017000 | 0 | 17.0 | 1.4 - 1.7 | 1.4 | |
Call | ADMA250919C00015000 | 4 | 15.0 | 2.55 - 2.75 | 3.5 | In |
Call | ADMA250919C00011000 | 3 | 11.0 | 4.9 - 7.2 | 7.1 | In |
Put | ADMA250919P00017000 | 0 | 17.0 | 1.2 - 1.85 | 1.2 | In |
Put | ADMA250919P00018000 | 8 | 18.0 | 2.15 - 2.45 | 1.72 | In |
Put | ADMA250919P00019000 | 0 | 19.0 | 2.9 - 3.2 | 2.99 | In |
Put | ADMA250919P00020000 | 0 | 20.0 | 3.6 - 3.9 | 3.6 | In |
Put | ADMA250919P00021000 | 0 | 21.0 | 4.5 - 4.8 | 4.5 | In |
Put | ADMA250919P00022000 | 0 | 22.0 | 4.4 - 6.5 | 4.4 | In |
Put | ADMA250919P00023000 | 0 | 23.0 | 5.1 - 8.0 | 5.1 | In |
Put | ADMA250919P00024000 | 0 | 24.0 | 6.0 - 9.4 | 6.0 | In |
Put | ADMA250919P00025000 | 0 | 25.0 | 7.1 - 9.9 | 7.1 | In |
Put | ADMA250919P00026000 | 0 | 26.0 | 8.0 - 10.9 | 8.0 | In |
ADMA Biologics Market Cap Over Time
Market Cap |
| Timeline |
ADMA Liabilities And Stockholders Equity
Liabilities And Stockholders Equity |
|
ADMA Biologics Corporate Management
| CPA CPA | CFO VP | Profile | |
| Michael Goldstein | General Counsel | Profile | |
| Neal Fitzpatrick | Vice Sales | Profile | |
| Kaitlin Kestenberg | Project Compliance | Profile | |
| Cyndi Tolman | VP Services | Profile | |
| Dr DPS | CoFounder Chairman | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ADMA Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ADMA Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.414 | Earnings Share 0.84 | Revenue Per Share | Quarterly Revenue Growth 0.402 | Return On Assets |
The market value of ADMA Biologics is measured differently than its book value, which is the value of ADMA that is recorded on the company's balance sheet. Investors also form their own opinion of ADMA Biologics' value that differs from its market value or its book value, called intrinsic value, which is ADMA Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ADMA Biologics' market value can be influenced by many factors that don't directly affect ADMA Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ADMA Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if ADMA Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.